SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-20-000064
Filing Date
2020-05-11
Accepted
2020-05-11 16:28:51
Documents
68
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sesn-20200331.htm   iXBRL 10-Q 1150814
2 EX-31.1 sesn-03312020x10qex311.htm EX-31.1 14632
3 EX-31.2 sesn-03312020x10qex312.htm EX-31.2 14557
4 EX-32.1 sesn-03312020x10qex321.htm EX-32.1 8475
5 EX-32.2 sesn-03312020x10qex322.htm EX-32.2 8440
  Complete submission text file 0001485003-20-000064.txt   5452288

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20200331.xsd EX-101.SCH 44026
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20200331_cal.xml EX-101.CAL 46265
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20200331_def.xml EX-101.DEF 202045
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20200331_lab.xml EX-101.LAB 520034
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20200331_pre.xml EX-101.PRE 329321
67 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20200331_htm.xml XML 854171
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 20865257
SIC: 2834 Pharmaceutical Preparations